Randomized, controlled trial of TRC101 to increase serum bicarbonate in patients with CKD
Clinical Journal of the American Society of Nephrology Jan 11, 2018
Bushinsky DA, et al. - This study entailed an assessment of TRC101, a novel, sodium-free, nonabsorbed hydrochloric acid binder, with respect to its efficacy and safety in increasing serum bicarbonate in patients with CKD and metabolic acidosis. Findings demonstrated that TRC101 afforded a safe and significant rise in the level of serum bicarbonate in patients with metabolic acidosis and CKD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
